Breaking News

Lonza, Vertex Break Ground for Cell Therapy Mfg. Facility

Large-scale manufacturing facility in Portsmouth, NH will support the commercial production of the Vertex T1D cell therapy portfolio.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Lonza and Vertex Pharmaceuticals broke ground for a dedicated manufacturing facility in Portsmouth, NH, marking a milestone in the strategic collaboration between the two companies, which aims to accelerate the development and commercialization of Vertex’s cell therapies for type 1 diabetes (T1D).   The new facility is being built adjacent to Lonza’s existing campus in Portsmouth and is a co-investment project between the two companies. Operated by Lonza, the facility will span more than 130,0...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters